These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34683845)

  • 41. [Ewing's sarcoma in children--current surgical treatment options, evaluation of our patients].
    Schovanec J; Mrácek J; Havlas V; Trc T
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):220-7. PubMed ID: 15456100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA SOX2 overlapping transcript acts as a miRNA sponge to promote the proliferation and invasion of Ewing's sarcoma.
    Ma L; Sun X; Kuai W; Hu J; Yuan Y; Feng W; Lu X
    Am J Transl Res; 2019; 11(6):3841-3849. PubMed ID: 31312393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management Head and Neck Ewing's Sarcoma Family of Tumors: Experience of the National Cancer Institute, Cairo University.
    Abdel Rahman H; El-Baradie T; El-Baradie M; Bahaa S; Shalan M
    J Egypt Natl Canc Inst; 2010 Mar; 22(1):41-7. PubMed ID: 21503005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways.
    Zhang S; Li D; Jiao GJ; Wang HL; Yan TB
    Onco Targets Ther; 2018; 11():7967-7977. PubMed ID: 30519038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
    Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
    J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.
    Guan H; Zhou Z; Gallick GE; Jia SF; Morales J; Sood AK; Corey SJ; Kleinerman ES
    Mol Cancer Ther; 2008 Jul; 7(7):1807-16. PubMed ID: 18644993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ewing's sarcoma: standard and experimental treatment options.
    Subbiah V; Anderson P; Lazar AJ; Burdett E; Raymond K; Ludwig JA
    Curr Treat Options Oncol; 2009 Apr; 10(1-2):126-40. PubMed ID: 19533369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Second cancers in long-term survivors of Ewing's sarcoma.
    Smith LM; Cox RS; Donaldson SS
    Clin Orthop Relat Res; 1992 Jan; (274):275-81. PubMed ID: 1729013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extraskeletal Ewing's sarcoma.
    Ahmad R; Mayol BR; Davis M; Rougraff BT
    Cancer; 1999 Feb; 85(3):725-31. PubMed ID: 10091746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ewing's sarcoma of bone tumor cells produces MCSF that stimulates monocyte proliferation in a novel mouse model of Ewing's sarcoma of bone.
    Margulies BS; DeBoyace SD; Damron TA; Allen MJ
    Bone; 2015 Oct; 79():121-30. PubMed ID: 26051470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children?
    Verrill MW; Judson IR; Harmer CL; Fisher C; Thomas JM; Wiltshaw E
    J Clin Oncol; 1997 Jul; 15(7):2611-21. PubMed ID: 9215832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
    Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and Expectations.
    Olmos D; Martins AS; Jones RL; Alam S; Scurr M; Judson IR
    Sarcoma; 2011; 2011():402508. PubMed ID: 21647361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ewing's Sarcoma of the Head and Neck: A Retrospective Analysis of 24 Cases.
    Allam A; El-Husseiny G; Khafaga Y; Kandil A; Gray A; Ezzat A; Schultz H
    Sarcoma; 1999; 3(1):11-5. PubMed ID: 18521259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
    Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
    Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EWS Knockdown and Taxifolin Treatment Induced Differentiation and Removed DNA Methylation from p53 Promoter to Promote Expression of Puma and Noxa for Apoptosis in Ewing's Sarcoma.
    Hossain MM; Ray SK
    J Cancer Ther; 2014 Oct; 5(12):1092-1113. PubMed ID: 27547487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemotherapy in the management of osteosarcoma and Ewing's sarcoma.
    Schuetze SM
    J Natl Compr Canc Netw; 2007 Apr; 5(4):449-55. PubMed ID: 17442235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
    Murakami T; Li S; Han Q; Tan Y; Kiyuna T; Igarashi K; Kawaguchi K; Hwang HK; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Hiroshima Y; Lwin TM; DeLong JC; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
    Oncotarget; 2017 May; 8(22):35630-35638. PubMed ID: 28404944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ewing's sarcoma with distant metastasis: A brief note on management and emerging therapies.
    Meshram GG; Kaur N; Hura KS
    Clin Pract; 2019 Aug; 9(3):1111. PubMed ID: 31579490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors.
    Hartman KR; Triche TJ; Kinsella TJ; Miser JS
    Cancer; 1991 Jan; 67(1):163-71. PubMed ID: 1985713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.